Home » Topics » BioWorld Science

BioWorld Science
RSS

Inventiosbio discloses new TYK2 inhibitors

July 19, 2022

Medshine Discovery patents IRAK4 and BTK inhibitors

July 19, 2022

Novel orally active NLRP3 inflammasome inhibitor alleviates DSS-induced colitis in mice

July 19, 2022

Amylyx sponsors research at SRI on Bax and Bak inhibitors for ALS and neurodegenerative diseases

July 19, 2022

PDE5A targeting enhances chemotherapy efficacy in esophageal adenocarcinoma

July 19, 2022

Fgg-impaired zebrafish present dysfibrinogenemia

July 19, 2022

Spread of Y chromosome deficiency in myeloid cells with age promotes cardiac fibrosis

July 18, 2022

Defective gamma fibrinogen crosslinking exacerbates liver injury

July 18, 2022

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

July 18, 2022

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...